Home » Newsletters » BioWorld

BioWorld

Feb. 22, 2001

View Archived Issues

U.S. Patent Disclosures

Pozen's First-Line Migraine Drug Meets Primary Phase III Endpoint

SYN X, genOway Combine Platforms In Collaboration

Other News To Note

Life Expectancy Rising, Though Not As Fast As Many Predicted

Cytovax Raises C$10M In IPO To Fund Phase I Of Cytovaxine

BIO Chief: Seasoned Leaders Ride Out Market, FDA Storms